Opinion

  • AI with intent and how Marion is changing how we think about work at SARD

    By Kevin Monk, CEO and co-founder at SARD JV For many organisations, the conversation about AI still begins with tools. Which model are we using? How powerful is it? How quickly can it generate outputs? In reality, most people still experience AI through a chat interface asking questions, generating text, or solving small, discrete problems. [...]

  • Technology exists everywhere: It’s leaders that must drive improvements

    By Darren Kilroy, medical director at RLDatix The findings from the GMC's latest workplace experiences report are stark. Doctor satisfaction fell from 59 per cent to 55 per cent in 2025, ending two years of gradual improvement. Burnout risk has risen to 20 per cent. The focus now should be understanding the why and how [...]

  • How clinical champions accelerated EPR adoption at Queen Victoria Hospital

    By Tamara Everington, chief medical officer at Queen Victoria Hospital NHS Foundation Trust When NHS organisations reflect on successful EPR implementations, the story often focuses on systems, suppliers and timelines. At Queen Victoria Hospital NHS Foundation Trust (QVH), the decisive factor was people. A strong network of clinical champions and super users helped translate a [...]

  • Mistrust of Palantir blamed as patients withdraw data from NHS research

    Health innovation minister James Frith said he was worried about “mistrust” of US defence and health tech company Palantir and “the impact it could have on people’s willingness to share data with the NHS”. The government is deciding whether to end Palantir's £330m contract to operate the NHS federated data platform, which is intended to [...]

  • AI’s impact on healthcare and life sciences investing

    By McDermott Will & Schulte Artificial intelligence is rapidly reshaping how healthcare and life sciences companies innovate, operate and invest. What was once viewed as a future consideration is now a present reality, with adoption accelerating at a pace that has exceeded expectations. Recent discussions, including those at our European Health and Life Sciences Symposium, [...]

  • Why haematology needs to measure what treatment asks of patients over time

    By Sanius Health One of the most overused words in oncology is "manageable". An adverse event can be clinically manageable and still change the structure of someone's life. It can be recorded as Grade 1 or Grade 2, recur across treatment cycles, erode sleep, reduce mobility, weaken appetite, impair cognition and quietly determine whether a [...]

  • Patient preference science is changing how we define a better treatment

    By Sanius Health As we enjoy the last days of Summer and head into September, one of the clearest shifts we are seeing across life sciences is a surge in demand for patient preference science. Some of that momentum reflects the work of Kielo Health, Sanius Health’s preference science division, led by Dr Tommi Tervonen, [...]

  • From invention to integration: The UK’s real quantum opportunity

    By Tracy Mcclelland, global chief clinical information officer (CCIO), Alcidion I am a nurse and CCIO, not a quantum scientist. I want to be clear about that upfront, because it shapes exactly what I think the UK’s most important quantum priority is, and why. Twenty-eight years of clinical practice and informatics leadership have taught me [...]

  • Beyond recruitment: Making better use of workforce capacity

    Paul Sanders, President UK and Ireland at RLDatix, discusses how workforce management technology can help NHS organisations make better use of workforce capacity. For years, the NHS workforce debate has focused on supply: recruitment, retention and vacancies. Those issues remain critical, but they can overshadow a second challenge that is becoming increasingly important: how organisations [...]

  • Veteran global health strategist joins FINN Partners as senior adviser

    FINN Partners, one of the world's largest independent communications and public affairs firms, has recruited Jeffrey L. Sturchio, a leading figure in international health policy, as a senior adviser to its Global Health Practice. Sturchio will sit within the firm's Health Policy and Impact Group, working alongside managing partner Mark Chataway on efforts to advise [...]